Human herpesvirus 7 detection by quantitative real time polymerase chain reaction in primary cutaneous T-cell lymphomas and healthy subjects: Lack of a pathogenic role

British Journal of Dermatology

Volumn 159, Issue 5, 2008, Pages 1131-1137

  Ponti, R ^a   Bergallo, M ^a   Costa, C ^a   Quaglino, P ^a   Fierro, M T ^a   Comessatti, A ^a   Stroppiana, E ^a   Sidoti, F ^a   Merlino, C ^a   Novelli, M ^a   Alotto, D ^b   Cavallo, R ^a   Bernengo, M G ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b CTO HOSPITAL   (Italy)

Author keywords

Cutaneous T cell lymphoma; D LUX primers technology; Human herpesvirus 7; Real time polymerase chain reaction

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CUTANEOUS T CELL LYMPHOMA; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN HERPESVIRUS 7; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; VIRUS DETECTION;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENES, T-CELL RECEPTOR GAMMA; HERPESVIRUS 7, HUMAN; HUMANS; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN NEOPLASMS; T-LYMPHOCYTES; YOUNG ADULT;

EID: 54249135483     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08811.x     Document Type: Article

References (34)

1. Willemze R, Kerl H, Sterry W et al. Classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 1997 90 : 354 71.
2. Willemze R, Jaffe ES, Burg G et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005 105 : 3768 85.
3. Lukowsky A, Richter S, Dijkstal K et al. A T-cell receptor gamma polymerase chain reaction assay using capillary electrophoresis for the diagnosis of cutaneous T-cell lymphomas. Diagn Mol Pathol 2002 11 : 59 66.
4. Vega F, Luthra R, Medeiros LJ et al. Clonal heterogeneity in mycosis fungoides and its relationship to clinical course. Blood 2002 100 : 3369 73.
5. Rübben A, Kempf W, Kadin ME et al. Multilineage progression of genetically unstable tumor subclones in cutaneous T-cell lymphoma. Exp Dermatol 2004 13 : 472 83.
6. Boni R, Davis-Daneshfar A, Burg G et al. No detection of HTLV-I proviral DNA in lesional skin biopsies from Swiss and German patients with cutaneous T-cell lymphoma. Br J Dermatol 1996 134 : 282 4.
7. Nagore E, Ledesma E, Collado C et al. Detection of Epstein-Barr virus and human herpesvirus 7 and 8 genomes in primary cutaneous T- and B-cell lymphomas. Br J Dermatol 2000 143 : 320 3.
8. Herne KL, Talpur R, Breuer-McHam J et al. Cytomegalovirus seropositivity is significantly associated with mycosis fungoides and Sézary syndrome. Blood 2003 101 : 2132 6.
9. Berneman ZN, Torelli G, Luppi M, Jarrett RF. Absence of a direct causative role for human herpesvirus 7 in human lymphoma and a review of human herpesvirus 6 in human malignancy. Ann Hematol 1998 77 : 275 8.
10. Kempf W, Kadin ME, Kutzner H et al. Lymphomatoid papulosis and human herpesviruses - a PCR-based evaluation for the presence of human herpesvirus 6, 7 and 8 related herpesviruses. J Cutan Pathol 2001 28 : 29 33.
11. Nicholas J. Determination and analysis of the complete nucleotide sequence of human herpesvirus. J Virol 1996 70 : 5975 89.
12. Kashanchi F, Araujo J, Doniger J et al. Human herpesvirus (HHV6) ORF-1 transactivating gene exhibits malignant transforming activity and its protein binding to p53. Oncogene 1997 14 : 359 67.
13. Tracey L, Villuendas R, Dotor AM et al. Mycosis fungoides shows concurrent deregulation of multiple genes involved in the TNF signaling pathway: an expression profile study. Blood 2003 102 : 1042 50.
14. Secchiero P, Mirandola P, Zella D et al. Human herpesvirus 7 induces the functional up-regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) coupled to TRAIL-R1 down-modulation in CD4(+) T cells. Blood 2001 98 : 2474 81.
15. Kashani-Sabet M, McMillan A, Zackheim HS. A modified staging classification for cutaneous T-cell lymphoma. J Am Acad Dermatol 2001 45 : 700 6.
16. Vonderheid EC, Bernengo MG. The Sézary syndrome: hematologic criteria. Hematol Oncol Clin North Am 2003 17 : 1367 89.
17. Bernengo MG, Novelli M, Quaglino P et al. The relevance of the CD4+ CD26- subset in the identification of circulating Sézary cells. Br J Dermatol 2001 44 : 2 3.
18. Ponti R, Quaglino P, Novelli M et al. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings. Br J Dermatol 2005 153 : 565 73.
19. Ponti R, Fierro MT, Quaglino P et al. TCRgamma-chain gene rearrangement by PCR-based GeneScan: diagnostic accuracy improvement and clonal heterogeneity analysis in multiple cutaneous t-cell lymphoma samples. J Invest Dermatol 2008 128 : 1030 8.
20. Kanavaros P, De Bruin PC, Briere J et al. Epstein-Barr virus (EBV) in extranodal T-cell non-Hodgkin's lymphomas (T-NHL). Identification of nasal T-NHL as a distinct clinicopathological entity associated with EBV. Leuk Lymphoma 1995 18 : 27 34.
21. Anagnostopoulos I, Hummel M, Kaudewitz P et al. Low incidence of Epstein-Barr virus presence in primary cutaneous T-cell lymphoproliferations. Br J Dermatol 1996 134 : 276 81.
22. Lee PY, Charley M, Tharp M et al. Possible role of Epstein-Barr virus infection in cutaneous T-cell lymphomas. J Invest Dermatol 1990 95 : 309 12.
23. Ghosh K. CMV seropositivity and mycosis fungoides - the Indian perspectives. Blood 2003 102 : 2706 7.
24. Gupta RK, Ramble J, Tong CY et al. Cytomegalovirus seroprevalence is not higher in patients with mycosis fungoides/Sézary syndrome. Blood 2006 107 : 1241 2.
25. Henghold WB 2nd., Purvis SF, Schaffer J et al No evidence of KSHV/HHV-8 in mycosis fungoides or associated disorders. J Invest Dermatol 1997 108 : 920 2.
26. Trento E, Castilletti C, Ferraro C et al. Human herpesvirus 8 infection in patients with cutaneous lymphoproliferative diseases. Arch Dermatol 2005 141 : 1235 42.
27. Black JB, Pellett PE. Human herpesvirus 7. Rev Med Virol 1999 9 : 245 62.
28. Caselli E, Di Luca D. Molecular biology and clinical associations of Roseoloviruses human herpesvirus 6 and human herpesvirus 7. New Microbiol 2007 30 : 173 87.
29. Hernández-Losa J, Fedele CG, Pozo F et al. Lack of association of polyomavirus and herpesvirus types 6 and 7 in human lymphomas. Cancer 2005 103 : 293 8.
30. Kempf W. Human herpesvirus 7 in dermatology: what role does it play? Am J Clin Dermatol 2002 3 : 309 15.
31. Kempf W, Burg G. Pityriasis rosea - a virus-induced skin disease? An update. Arch Virol 2000 145 : 1509 20.
32. Watanabe T, Kamamura T, Jacob SE. Pityriais rosea is associated with systemic active infection with both human herpesvirus 7 and human herpesvirus 6. J Invest Dermatol 2002 119 : 793 7.
33. Kirby B, Al-Jiffri O, Cooper RJ et al. Investigation of cytomegalovirus and human herpes virus 6 and 7 as possible causative antigens in psoriasis. Acta Derm Venereol 2000 80 : 404 6.
34. Kempf W, Adams V, Kleinhans M et al. Pityriasis rosea is not associated with human herpesvirus 7. Arch Dermatol 1999 135 : 1070 2.